New sensor aims to predict heart failure readmissions without needles

NCT ID NCT07671742

Recruiting now Knowledge-focused Sponsor: Acorai AB Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a non-invasive device that uses sensors placed on the chest to monitor heart failure patients during their hospital stay and for 90 days after discharge. The goal is to see if the device's measurements can help predict which patients are at higher risk of being readmitted or dying. The study involves 1,000 adults hospitalized for heart failure and does not change their medical care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simple, non-invasive way to monitor heart failure patients and predict who is at risk of readmission or death after hospitalization.
What could go wrong: This is an observational study, not a treatment trial. The device is not being tested to improve outcomes, only to see if its measurements relate to patient health. Results may not lead to any new device or change in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE HEART FAILURE (HF) HEART FAILURE HOSPITALIZATION

Contacts and locations

Locations

Skåne University Hospital
RECRUITING

Lund, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.